Neurotechnology Offers Hope For Better Anxiety And Depression Treatments
SINTEF researcher Sandra Klonteig says brain measurements could help identify mental health changes and guide treatment, but clinical benefits remain unproven.
Psychotherapist Steve Hauptman reflects on the limits of control and why accepting tradeoffs can help people stop treating every compromise as failure.
Scientists May Have Overlooked A Hidden Alzheimer’s Culprit For Decades
A ChemBioChem commentary argues that P3, a peptide long considered harmless, can form aggregates and may affect Alzheimer’s disease. Its role in patients is unknown.